Senores Pharmaceuticals has taken a major step forward in its global growth journey by announcing a strategic joint venture to expand its presence in the United States federal healthcare market. This move highlights the company’s ambition to stren...
UPSIDA & JNPA pact is set to reshape India’s pharma export landscape. The Uttar Pradesh State Industrial Development Authority (UPSIDA) partners with Jawaharlal Nehru Port Authority (JNPA) to position the Lalitpur Pharma Park as a global export hub.
Bayer simplifies access to Eylea 2mg in India, enabling early treatment for retinal diseases like Wet AMD and DME, improving patient access and reducing cost barriers.
Emcure Pharmaceuticals has sharply cut the price of its weight loss drug Poviztra across India, slashing costs by an average of 47% to make the semaglutide based treatment more affordable for patients.The reduced pricing takes effect from April 3,
Explore the evolution of Pharma CDMOs in India and the rise of the CDMO 2.0 model in 2026. Discover key trends, market growth, biologics, digital transformation, and why India is emerging as a global hub for contract development and manufacturing.
ZEISS India has launched its new ClearMind lenses today, bringing a fresh approach to everyday vision. The ClearMind lenses are designed to deliver sharper clarity while reducing the cognitive load caused by blurry vision, making them ideal for...
Takeda Pharmaceutical Company is a step closer to dengue vaccine Import approval in India after receiving a positive recommendation from the Subject Expert Committee, marking a major development in the country’s fight against mosquito-borne diseases.
Novo Nordisk is set to cut the Ozempic price in India as Indian generics flood the market following the patent expiry.
India’s pharmaceutical industry is grappling with a severe raw material crisis, putting immense pressure on API producers. Prices of key chemicals and Active Pharmaceutical Ingredients (APIs) have skyrocketed, forcing manufacturers to cut production
Alkem Laboratories has announced the launch of its semaglutide injection in India, introducing a more affordable option for patients managing type 2 diabetes and weight issues.
.jpg)
, CDSCO.jpg)